SCHEMBL9973

SCHEMBL9973

CCOC(=O)CCc1ccc(-c2ccccc2)c(-c2onc(C)c2Nc2cccc(-c3ccccc3)n2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 5/20 0.38
PTPN1 P18031 4/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HPGD P15428 3/20 0.38
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
P2RY12 Q9H244 1/20 0.37
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
PARP1 P09874 1/20 0.36
SQOR Q9Y6N5 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
PKM P14618 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10090 0.90 RXRA (0.38)
SCHEMBL5049 0.88 LPAR1 (0.42) SYKALDH1A1KDM4EHPGDCYP4F2
SCHEMBL9972 0.82 LPAR1 (0.39) PTPN1ALDH1A1KDM4EHPGDP2RY12
SCHEMBL5388 0.81 LPAR1 (0.47) SYKALDH1A1KDM4EHPGDKMT2A
SCHEMBL9783 0.80 OPRM1 (0.38) LMNA
SCHEMBL9632 0.80 ALDH1A1 (0.43) SYKPTPN1ALDH1A1KDM4EHPGD
SCHEMBL10135 0.79 LMNA (0.39) LMNA
SCHEMBL9974 0.78 LPAR1 (0.40) ALDH1A1KDM4EHPGDP2RY12MEN1
SCHEMBL4137 0.77 FFAR1 (0.46) KDM4EHPGDLMNA
SCHEMBL10089 0.77 AKR1C3 (0.42) HPGDMEN1KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed